Armata Pharmaceuticals (ARMP) Earnings Date & Reports

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ARMP is expected to report earnings to rise 51.85% to -40 cents per share on November 18

Armata Pharmaceuticals ARMP Stock Earnings Reports

Q3'26

Est.

$-0.41

Q2'26

Beat

by $0.17

Q4'25

Missed

by $3.23

Q3'25

Missed

by $0.24

Q2'25

Missed

by $0.06

The last earnings report on August 12 showed earnings per share of -27 cents, beating the estimate of -43 cents. With 124.48K shares outstanding, the current market capitalization sits at 140.55M.

View a ticker or compare two or three

ARMP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ARMP